Abstract
GreenLight Biosciences plans to expand its operation in Research Triangle Park, North Carolina, where it researches use of RNA-based products for insect, fungus, and weed control. The firm is adding a greenhouse and labs and says it will have 60 employees there by the end of the year. GreenLight expects its first product, for controlling the Colorado potato beetle, to win US approval this year. It will go public in the coming months by merging with a special purpose acquisition company in a deal that could value it at $1.2 billion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
